News Archives - Page 3 of 3

Skip to content

The Platform
The Services
Services
01. Virtual Patient Experience

02. Telehealth

03. Lab Testing
04. Prescription Fulfillment

05. Benefits Verification, Claims and Payment

06. Connected Care
The Company
Resources

Contact us

The Platform

The Services

Virtual Patient Experience
Telehealth
Lab Testing
Prescription Fulfillment
Benefits Verification
Connected Care

The Company

Resources

Contact us

Resources

Industry Insights

The latest research, news and expert opinion keeping you up to date on DTP industry innovation.

News

Fierce Pharma Highlights How Direct-to-Patient Programs Are Becoming Standard Practice

Fierce Pharma Highlights How Direct-to-Patient Programs Are Becoming Standard Practice Fierce Pharma recently spotlighted findings from ixlayer’s latest survey of

Blog

Pharma’s Next Move: What 2025 Survey Data Reveals About the Future of Direct-to-Patient Programs

Direct-to-patient (DTP) programs are no longer experimental. According to a new 2025 survey conducted by ixlayer and The DHC Group

Blog

Recap: Peer-to-Peer Lunch at Fierce Pharma Week – Building Direct-to-Patient Programs That Work

Recap: Peer-to-Peer Lunch at Fierce Pharma Week – Building Direct-to-Patient Programs That Work At this year’s Fierce Pharma Week, ixlayer

Press Release

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next Year, and Half Say DTP Will Be Standard Practice Within Five Years

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next

Blog

Services

Virtual Patient Experience
Telehealth
Lab Testing
Prescription Fulfillment
Benefits Verification
Connected Care

The Company

News
Resource Center
Blog
Content Library

Get In Touch

Corporate Office - West Coast

IX Layer Inc.
447 Sutter Street, Suite 405, PMB 53
San Francisco, CA 94108

Corporate Office - East Coast

IX Layer Inc.
222 Broadway, 22nd Floor
New York, NY 10038

Email: contact@ixlayer.com

Consent Preferences

Privacy Policy
Terms of Service
Security & Compliance

Services

Fierce Pharma Highlights How Direct-to-Patient Programs Are Becoming Standard Practice

Pharma’s Next Move: What 2025 Survey Data Reveals About the Future of Direct-to-Patient Programs

Recap: Peer-to-Peer Lunch at Fierce Pharma Week – Building Direct-to-Patient Programs That Work

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next Year, and Half Say DTP Will Be Standard Practice Within Five Years

Compliance Considerations for Direct-to-Patient Programs: What Pharma Needs in a Trusted Partner

ixlayer Takes “Healthcare Technology Innovation of the Year” in the 2025 Stevie Awards for Technology Excellence

Breaking the Cycle: Direct-to-Patient Campaigns Can Improve Access for Migraine Patients

ixlayer and L.A. Care Health Plan Win the 2025 Fierce DEI Award for “Outstanding DEI Initiative in Patient Care”

Key Takeaways from the 2025 ixlayer Client Advisory Meeting